Stock SYNTA PHARMACEUTICALS CORP.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Synta Pharmaceuticals Corp. Nasdaq

Equities

US87162T2069

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Synta Pharmaceuticals Corp.
04-22 BofA Securities Initiates Coverage of Madrigal Pharmaceuticals with Underperform Rating, $150 Price Objective MT
04-22 BofA Securities Starts Madrigal Pharmaceuticals With Underperform Rating, $150 Price Target MT

Chart calendar Synta Pharmaceuticals Corp.

5f1e6b41b1a8d.LNtMywWUf6DCbGOLemKIH_mXW3UyXqdopGIE7X7aZVQ.Rpd1jGnGFvf7IRvTAhfPT6PuGixoHZEBzBdcgzKXXSccogW7RqET9p1ZLg~7a1b8132ba12f91d2ca329a347e16de0

Upcoming events on Synta Pharmaceuticals Corp.

07/05/2024 12:00 Q1 2024 Earnings Release
07/05/2024 13:00 Q1 2024 Earnings Call
05/08/2024 Q2 2024 Earnings Release (Projected)
05/11/2024 Q3 2024 Earnings Release (Projected)
25/02/2025 Q4 2024 Earnings Release (Projected)
12/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Synta Pharmaceuticals Corp.

14/03/2024 21:15 Rezdiffra™ (resmetirom) Accelerated Approval Call
28/02/2024 12:00 Q4 2023 Earnings Release
11/01/2024 00:30 JPMorgan Healthcare Conference
03/01/2024 NASH TAG Conference - Abstract No:27
03/01/2024 NASH TAG Conference - Abstract No:26
03/01/2024 NASH TAG Conference - Abstract No:25
03/01/2024 NASH TAG Conference - Abstract No:21
03/01/2024 NASH TAG Conference - Abstract No:41
30/11/2023 18:00 Piper Sandler Healthcare Conference
29/11/2023 20:00 Evercore ISI HealthCONx Conference
08/11/2023 22:00 UBS BioPharma Conference
06/11/2023 13:00 Q3 2023 Earnings Release
08/08/2023 13:00 Q2 2023 Earnings Release
24/06/2023 17:30 European Association for the Study of the Liver Congress
15/06/2023 14:00 Annual General Meeting
13/06/2023 17:20 Goldman Sachs Global Healthcare Conference
07/06/2023 19:30 Jefferies Global Healthcare Conference
16/05/2023 15:30 JMP Securities Life Sciences Conference
09/05/2023 13:00 Q1 2023 Earnings Release
13/03/2023 14:40 Oppenheimer Healthcare Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
81,7

EBITDA
Million USD		Released
Forecast
Spread 		-94,9
-93,5
-1.44%		-206
-209
1.32%		-242
-244
0.7%		-293
-291
-0.77%		-380
-379
-0.29%
-570

EBIT
Million USD		Released
Forecast
Spread 		-95,0
-93,4
-1.66%		-207
-209
1.12%		-242
-244
0.66%		-294
-286
-2.59%		-380
-372
-2.42%
-496

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-83,9
-80,3
-4.57%		-202
-203
0.44%		-242
-242
0.26%		-295
-286
-3.35%		-374
-364
-2.75%
-462

Net income
Million USD		Released
Forecast
Spread 		-83,9
-80,3
-4.6%		-202
-203
0.44%		-242
-243
0.44%		-295
-287
-2.85%		-374
-365
-2.29%
-459

EPS
USD		Released
Forecast
Spread 		-5,45
-5,30
-2.74%		-13,1
-13,2
1.11%		-14,6
-14,7
0.21%		-17,2
-16,8
-2.69%		-20,0
-19,4
-2.78%
-23,3

Announcement Date26/02/2025/02/2124/02/2223/02/2328/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


3,97


25,6


51,3


40,4

EBITDA
Million USD		Released
Forecast
Spread














-78,2
-88,5
11.6%









-129


-138


-142


-135




EBIT
Million USD		Released
Forecast
Spread 		-64,6
-66,2
2.42%		-57,6
-60,6
4.98%		-70,3
-63,8
-10.22%		-80,4
-73,0
-10.17%		-85,3
-77,9
-9.49%		-78,3
-86,7
9.6%		-86,5
-84,7
-2.03%		-98,5
-92,9
-6.02%		-117
-108
-8.27%
-130


-140


-132


-113


-132

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-64,5
-65,2
1.01%		-57,5
-58,6
1.89%		-70,7
-65,3
-8.24%		-81,2
-71,3
-13.81%		-85,9
-76,6
-12.18%		-76,9
-87,8
12.46%		-85,8
-83,5
-2.71%		-98,7
-89,9
-9.86%		-112
-103
-8.51%
-125


-136


-123


-101


-110

Net income
Million USD		Released
Forecast
Spread 		-64,5
-65,6
1.67%		-57,5
-60,0
4.06%		-70,7
-64,1
-10.29%		-81,2
-72,6
-11.89%		-85,9
-77,9
-10.23%		-76,9
-86,7
11.32%		-85,8
-82,6
-3.94%		-98,7
-90,1
-9.64%		-112
-105
-7.1%
-123


-132


-121


-102


-110

EPS
USD		Released
Forecast
Spread 		-3,79
-3,86
1.8%		-3,36
-3,56
5.72%		-4,14
-3,68
-12.54%		-4,75
-4,14
-14.77%		-4,98
-4,50
-10.57%		-4,23
-4,99
15.15%		-4,69
-4,55
-3.12%		-5,34
-4,88
-9.4%		-5,68
-5,26
-7.88%
-6,20


-6,54


-6,10


-5,13


-6,25

Announcement Date24/02/2209/05/2204/08/2203/11/2223/02/2309/05/2308/08/2306/11/2328/02/24-----

Upcoming sector events for Synta Pharmaceuticals Corp.

05/05/2024 FRAZIER LIFESCIENCES ACQUISITION CORPORATION: Q1 2024 Earnings Release (Projected)
05/05/2024 KRYSTAL BIOTECH, INC.: Q1 2024 Earnings Release
05/05/2024 MERUS N.V.: Q1 2024 Earnings Release (Projected)
05/05/2024 VAXCYTE, INC.: Q1 2024 Earnings Release (Projected)
05/05/2024 INHIBRX, INC.: Q1 2024 Earnings Release (Projected)
05/05/2024 BIONTECH SE: Q1 2024 Earnings Release
06/05/2024 12:00 BIOCRYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
06/05/2024 21:01 VERTEX PHARMACEUTICALS INCORPORATED: Q1 2024 Earnings Release
06/05/2024 COGENT BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected)
06/05/2024 LYELL IMMUNOPHARMA, INC.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for Synta Pharmaceuticals Corp.

03/05/2024 12:00 GH RESEARCH PLC: Q1 2024 Earnings Release
02/05/2024 21:05 KURA ONCOLOGY, INC.: Q1 2024 Earnings Release
02/05/2024 21:05 ZYMEWORKS INC.: Q1 2024 Earnings Release
02/05/2024 21:02 ARDELYX, INC.: Q1 2024 Earnings Release
02/05/2024 21:01 LONGBOARD PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
02/05/2024 21:01 ASCENDIS PHARMA A/S: Q1 2024 Earnings Release
02/05/2024 21:00 ULTRAGENYX PHARMACEUTICAL INC.: Q1 2024 Earnings Release
02/05/2024 16:00 GENMAB A/S: Q1 2024 Earnings Release
02/05/2024 12:00 GERON CORPORATION: Q1 2024 Earnings Release
02/05/2024 12:00 AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. MDGL Stock
  4. Stock
  5. Calendar Synta Pharmaceuticals Corp.